Covered recipient · General Payments record
CHRISTOPHER MICHAEL CALZETTA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$7,068.03
- Reported across 408 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $837.76 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $545.43 | 23 |
| Alkermes, Inc. | $59.44 | 3 |
| Otsuka America Pharmaceutical, Inc. | $59.32 | 3 |
| Teva Pharmaceuticals USA, Inc. | $51.46 | 2 |
| Axsome Therapeutics, Inc. | $44.64 | 2 |
| Janssen Pharmaceuticals, Inc | $32.35 | 1 |
| Lundbeck LLC | $23.18 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.24 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867649 | CMS |
| ABBVIE INC. | $17.52 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867651 | CMS |
| ABBVIE INC. | $32.96 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867653 | CMS |
| ABBVIE INC. | $12.42 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867655 | CMS |
| ABBVIE INC. | $22.39 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867657 | CMS |
| ABBVIE INC. | $20.88 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867659 | CMS |
| ABBVIE INC. | $13.57 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867661 | CMS |
| ABBVIE INC. | $33.91 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867663 | CMS |
| ABBVIE INC. | $23.93 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867665 | CMS |
| ABBVIE INC. | $29.47 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867667 | CMS |
| ABBVIE INC. | $33.71 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867669 | CMS |
| ABBVIE INC. | $27.52 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867671 | CMS |
| ABBVIE INC. | $30.80 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867673 | CMS |
| ABBVIE INC. | $31.06 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867675 | CMS |
| ABBVIE INC. | $20.52 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867677 | CMS |
| ABBVIE INC. | $19.91 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867679 | CMS |
| ABBVIE INC. | $33.09 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867681 | CMS |
| ABBVIE INC. | $30.41 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867683 | CMS |
| ABBVIE INC. | $25.52 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867685 | CMS |
| ABBVIE INC. | $20.30 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867687 | CMS |
| ABBVIE INC. | $28.22 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867689 | CMS |
| ABBVIE INC. | $6.60 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867691 | CMS |
| ABBVIE INC. | $17.48 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106867693 | CMS |
| Alkermes, Inc. | $24.28 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120475260 | CMS |
| Alkermes, Inc. | $20.24 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120475262 | CMS |
| Alkermes, Inc. | $14.92 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120475264 | CMS |
| Axsome Therapeutics, Inc. | $21.38 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148348583 | CMS |
| Axsome Therapeutics, Inc. | $23.26 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148348585 | CMS |
| Janssen Pharmaceuticals, Inc | $32.35 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077931795 | CMS |
| Lundbeck LLC | $23.18 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146001922 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.56 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119038779 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.34 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119038781 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.42 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119038783 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.94 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137721674 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.25 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151565323 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.21 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151565353 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.